Clinical Trial Update: A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating brexpiprazole in combination with ketamine for treatment-resistant depression has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)
• brexpiprazole (brexpiprazole)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Depression | Phase 4 | Status: COMPLETED | Results posted: 2020-07-24